News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter
Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

Celebrities and Cancer
Cancer Types
Radiotherapy
Science
Trial Updates
ASCO
ESMO
ESO
MASCC
Cancer Center Near Me
Immune Oncology
Oncologist Near Me
OncoDaily Party 2025

Childhood Cancer
Health Policy
Hall of Fame
OncoIndustry
Public Health
Oncology Tech
Blog Posts
BIGR
Global Cancer Movement
History
Oncolibrary
OncoThon 2025
Yvonne Award 2025

Feb / 2026

February 2026
M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

« Jan

OncoDaily IO OncoDaily GI Hemostasis Today Fertility News

Voices
Not To Miss
FDA Approvals
New Paper Alert
OncoDaily 100
Community
OncoDaily Magazine
Career Updates
Oncology Drugs
Dialogues
Stories

News Feed
OncoDaily Pulse
OncoGrants
OncoDaily TV
NewsLetter

Gold After Cancer: Winter Olympic Legends on the Road to Milano-Cortina 2026

Gold After Cancer: Winter Olympic Legends on the Road to Milano-Cortina 2026

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

KEYNOTE-905/EV-303 Trial: Perioperative Enfortumab Vedotin and Pembrolizumab in Muscle-Invasive Bladder Cancer

Call for Papers: Special Series on Cancer in the Middle East in 2026

Call for Papers: Special Series on Cancer in the Middle East in 2026

Promising MRI Methods for Understanding Glioblastoma Biology - Mark Hughes Foundation Centre for Brain Cancer Research

Promising MRI Methods for Understanding Glioblastoma Biology - Mark Hughes Foundation Centre for Brain Cancer Research

The 12th Edition of the SIOG Advanced Course Returns to Treviso in 2026

The 12th Edition of the SIOG Advanced Course Returns to Treviso in 2026

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

Inside The Breast Friends Podcast With Paolo Tarantino and Jason Mouabbi

Inside The Breast Friends Podcast With Paolo Tarantino and Jason Mouabbi

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

William Y. Kim

Dec 19, 2025 5:50 pm

Voices

Michael Sturdivant: Identifying APOBEC3A’s Association with Squamous Differentiation in Urothelial Carcinoma

Michael Sturdivant: Identifying APOBEC3A’s Association with Squamous Differentiation in Urothelial Carcinoma

Sep 24, 2024 12:30 pm

Societies

11 ESMO24 presentations published on NEJM

11 ESMO24 presentations published on NEJM

May 20, 2024 2:23 pm

Blog Posts

Shahla Bari: Duke’s 1st Kidney cancer and microbiome symposium

Shahla Bari: Duke’s 1st Kidney cancer and microbiome symposium

Headlines

ESTRO Elections 2026: Who Will Lead the Future of Radiation Oncology?

CheckMate 649: 5-Year Results of First-Line Nivolumab Plus Chemotherapy in Advanced Gastric, GEJ, and Esophageal Adenocarcinoma

Nominations Now Open for the 2026-2028 Board of Directors and President-Elect - UICC

Platform Redesign, Allogeneic Feasibility, and Histology-Specific Dosing: Lessons from Tandem 2026 for CAR-T Cell Therapy

Sanofi CEO Change: Paul Hudson Exits as Belén Garijo Named Next CEO

CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

About Privacy Policy Editorial Policy Cookie Policy Disclaimer

Crafted by Matemat

Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research Headlines ESMO MD Anderson Cancer Center immunotherapy NSCLC cancer treatment cancer awareness Research ASCO24 colorectal cancer Childhood Cancer clinical trials prostate cancer AACR FDA UICC Dana-Farber Cancer Institute American Cancer Society European Cancer Organisation SIOP chemotherapy Myeloma NCI Robert Orlowski Vivek Subbiah National Cancer Institute American Society of Clinical Oncology Myeloma Paper of the Day Pancreatic Cancer healthcare Paolo Tarantino radiation oncology cervical cancer AI IASLC ASCO25 WHO Zainab Shinkafi-Bagudu multiple myeloma Memorial Sloan Kettering Cancer Center

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}